Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

5AM hires Anna Yaeger as head of public equities

Plus Scripps alum Maricich becomes Ashvattha CMO and updates from Alexion, Rewind, ExeVir and more

October 20, 2022 10:16 PM UTC

5AM Ventures hired Anna Yaeger as partner, head of public equities. Yaeger was president and portfolio manager at Ally Bridge Group and portfolio manager at Point72 Asset Management, having begun her career at Goldman Sachs. The firm manages about $500 million in publicly traded securities.

Dendrimer therapeutics company Ashvattha Therapeutics Inc. hired Steve Maricich as CMO. Maricich was CMO at Calibr and Scripps BioVentures. Ashvattha, a spinout of The Johns Hopkins University, raised a $69 million series B round to develop a pair of hydroxyl dendrimer therapeutics targeted to inflammatory cells in specific tissues...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article